Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog – Page 11109

IBM Watson is known for its work in identifying cancer treatments and beating contestants on Jeopardy! But now the computing system has expertise in a new area of research: neuroscience.

Watson discovered five genes linked to ALS, sometimes called Lou Gehrig’s disease, IBM announced on Wednesday. The tech company worked with researchers at the Barrow Neurological Institute in Phoenix, Arizona. The discovery is Watson’s first in any type of neuroscience, and suggests that Watson could make discoveries in research of other neurological diseases.

SEE ALSO: This high-tech E.L.F. is guiding confused shoppers with the help of IBM’s Watson.

Read more

In news certain to take the bounce out of your step, a NASA scientist says Earth is due for an “extinction-level” event that we basically would have no way of stopping.

Dr. Joseph Nuth of NASA’s Goddard Space Flight Center rang the alarm Monday in San Francisco, New York Magazine reports. The comet that spelled disaster for the dinosaurs hit 65 million years ago, and Nuth said the massive asteroids and comets that could wipe out civilization usually strike “50 to 60 million years apart,” making such an event overdue.

In 2014, scientists first spotted a large comet barreling toward Mars just 22 months before it came perilously close to hitting the planet. That wasn’t enough time to do anything, Nuth said, proof that “the biggest problem, basically, is there’s not a hell of a lot we can do about it at the moment.” To prevent a catastrophic event, Nuth suggests NASA create a rocket that can go in storage, ready to be used if a huge comet comes our way. “It could mitigate the possibility of a sneaky asteroid coming in from a place that’s hard to observe, like from the sun,” Nuth said. The way 2016 has gone so far, you might want to start scanning the sky. Catherine Garcia.

Read more

New article on immigration and AI in The Guardian. https://www.theguardian.com/technology/2016/dec/14/donald-tr…automation #future

All of this could be under threat if we are to take some of the comments the Trump campaign made in the run-up to the election at face value. The outspoken candidate claimed that Mark Zuckerberg’s push for specialist H1B visas (the main visa used to hire foreign talent to tech companies) was a threat to jobs for American women and minorities. Meanwhile, Trump’s chief strategist Steve Bannon suggested that Asians have too much power in Silicon Valley.

About a dozen members of Silicon Valley’s elite – including Apple CEO Tim Cook, Alphabet CEO Larry Page, Microsoft CEO Satya Nadella and Facebook COO Sheryl Sandberg – will meet with Trump in New York. The meeting is likely to provide an opportunity for them to highlight their concerns and priorities with the incoming administration.

Trump was critical of Silicon Valley business practices during his campaign – from wanting Apple to stop making phones in China to saying Amazon founder Jeff Bezos bought the Washington Post to exert political power and avoid paying taxes.

“If you look at the history of Silicon Valley, it’s clear that drawing on immigrants has been a big part of the vitality, creativity and success of that entrepreneurial melange,” said Marjory Blumenthal, senior policy analyst at Rand Corporation.

Read more

Senescent cell removal holds great potential but are all research approaches equal?

Some scientific commentary on senescent cell clearing (Senolytics) and the different approaches the research community is engaged in.

“Researchers are taking two broad approaches to cellular senescence at the present time. The first is to build therapies that can selectively destroy senescent cells, following the SENS rejuvenation model of periodic removal of damage. If the number of senescent cells is managed so as to keep that count low, then they will not cause further harm. This has the advantage of being straightforward and requiring little further research to put into practice. A range of demonstrated treatments and potential treatments already exist — gene therapies, immunotherapies, senolytic drugs, and so forth — and companies such as Oisin Biotechnologies and UNITY Biotechnology are bringing some of these technologies to the clinic.”

Read more

Synthetic biology meets senolytics at Lifespan.io

We are developing tools to help researchers accurately target and remove dysfunctional cells in the body that have entered a state called “senescence”, and thereby assist in restoring it to youthful functionality. Please subscribe, share, and fund our campaign today! ►Campaign Link: https://www.lifespan.io/campaigns/cellage-targeting-senescen…c-biology/ ►Subscribe: https://www.youtube.com/user/LifespanIO?sub_confirmation=1

Our society has never aged more rapidly – one of the most visible symptoms of the changing demographics is the exponential increase in the incidence of age-related diseases, including cancer, cardiovascular diseases and osteoarthritis. Not only does aging have a negative effect on the quality of life among the elderly but it also causes a significant financial strain on both private and public sectors. As the proportion of older people is increasing so is health care spending. According to a WHO analysis, the annual number of new cancer cases is projected to rise to 17 million by 2020, and reach 27 million by 2030. Similar trends are clearly visible in other age-related diseases such as cardiovascular disease. Few effective treatments addressing these challenges are currently available and most of them focus on a single disease rather than adopting a more holistic approach to aging.

Continue reading “CellAge: Senescent Cell Targeting Technology Video” | >

Dr. Aubrey de Grey from the SENS Research Foundation was kind enough to talk in support of CellAge and their campaign on Lifespan.io

We are developing tools to help researchers accurately target and remove dysfunctional cells in the body that have entered a state called “senescence”, and thereby assist in restoring it to youthful functionality. Please subscribe, share, and fund our campaign today! ►Campaign Link: https://www.lifespan.io/campaigns/cellage-targeting-senescen…c-biology/ ►Subscribe: https://www.youtube.com/user/LifespanIO?sub_confirmation=1

Our society has never aged more rapidly – one of the most visible symptoms of the changing demographics is the exponential increase in the incidence of age-related diseases, including cancer, cardiovascular diseases and osteoarthritis. Not only does aging have a negative effect on the quality of life among the elderly but it also causes a significant financial strain on both private and public sectors. As the proportion of older people is increasing so is health care spending. According to a WHO analysis, the annual number of new cancer cases is projected to rise to 17 million by 2020, and reach 27 million by 2030. Similar trends are clearly visible in other age-related diseases such as cardiovascular disease. Few effective treatments addressing these challenges are currently available and most of them focus on a single disease rather than adopting a more holistic approach to aging.

Continue reading “CellAge: Dr. Aubrey de Grey Endorsement Video” | >